Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
Study NCT ID:
NCT03989466
Status:
COMPLETED
Last Update Posted:
2024-10-10
First Post:
2019-06-14
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-24
Completion Date Type:
ACTUAL
First Submit Date:
2019-06-14
First Submit QC Date:
None
Study First Post Date:
2019-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-10-10
Last Update Post Date Type:
ACTUAL